The goal of this clinical trial is to determine whether intravenous (IV) lidocaine reduces the incidence of perioperative respiratory complications (PRCs) in children with upper respiratory tract infections undergoing general anesthesia. The study will also evaluate the safety of IV lidocaine in this population. The main questions it aims to answer are: 1. Does IV lidocaine lower the incidence of perioperative respiratory complications (e.g., laryngospasm, cough, desaturation) compared to a placebo? 2. What are the side effects associated with the administration of IV lidocaine in these children? Researchers will compare IV lidocaine to a placebo to assess its effectiveness in reducing PRCs.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
102
IV lidocaine, administered once during the induction of anesthesia.
IV placebo (normal saline), administered once during the induction of anesthesia.
Bechir Hamza Children's Hospital
Tunis, Tunisia
Incidence of Perioperative Respiratory Complications
Measure the occurrence of perioperative respiratory complications (e.g., laryngospasm, cough, desaturation, bronchospasm) from the induction of anesthesia until discharge from the recovery room.
Time frame: Within the first 2 hours post-operation.
Incidence of Side Effects Related to IV Lidocaine
Measure the occurrence of side effects such as nausea, vomiting, cardiac or neurological toxicity, and signs of anaphylaxis following the administration of IV lidocaine.
Time frame: Within the first 24 hours post-operation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.